JAMES CAI: Open Payments
NPI 1215331152 · EDISON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,711 in 70 payments from 19 companies in 2025. Trend: 2023 $1,768 · 2024 $1,744 · 2025 $1,711
Food & beverage: $1,711
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $375 |
| AstraZeneca Pharmaceuticals LP | 10 | $209 |
| Esperion Therapeutics, Inc. | 11 | $202 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $145 |
| GlaxoSmithKline, LLC. | 8 | $141 |
| Gilead Sciences, Inc. | 4 | $121 |
| ABBVIE INC. | 6 | $117 |
| PFIZER INC. | 3 | $80 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
Products named: NEXLETOL, EVENITY, REPATHA, Kerendia, FARXIGA, TRELEGY ELLIPTA, OTEZLA, UBRELVY.
Industry payments across NJ — which companies pay providers there.
